Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15


Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder.

Madden JM, Lakoma MD, Lynch FL, Rusinak D, Owen-Smith AA, Coleman KJ, Quinn VP, Yau VM, Qian YX, Croen LA.

J Autism Dev Disord. 2017 Jan;47(1):144-154. doi: 10.1007/s10803-016-2946-7.


Fluoxetine for Autistic Behaviors (FAB trial): study protocol for a randomized controlled trial in children and adolescents with autism.

Mouti A, Reddihough D, Marraffa C, Hazell P, Wray J, Lee K, Kohn M.

Trials. 2014 Jun 16;15:230. doi: 10.1186/1745-6215-15-230.


Engagement in vocational activities promotes behavioral development for adults with autism spectrum disorders.

Taylor JL, Smith LE, Mailick MR.

J Autism Dev Disord. 2014 Jun;44(6):1447-60. doi: 10.1007/s10803-013-2010-9.


Prevalence and Predictors of Psychotropic Use in Children with High-Functioning ASDs.

Lopata C, Toomey JA, Fox JD, Thomeer ML, Volker MA, Lee GK.

Autism Res Treat. 2013;2013:384527. doi: 10.1155/2013/384527. Epub 2013 May 16.


Pharmacotherapy for the core symptoms in autistic disorder: current status of the research.

Farmer C, Thurm A, Grant P.

Drugs. 2013 Mar;73(4):303-14. doi: 10.1007/s40265-013-0021-7. Review.


Age-related variation in health service use and associated expenditures among children with autism.

Cidav Z, Lawer L, Marcus SC, Mandell DS.

J Autism Dev Disord. 2013 Apr;43(4):924-31. doi: 10.1007/s10803-012-1637-2.


Changes in maladaptive behaviors from midchildhood to young adulthood in autism spectrum disorder.

Anderson DK, Maye MP, Lord C.

Am J Intellect Dev Disabil. 2011 Sep;116(5):381-97. doi: 10.1352/1944-7558-116.5.381.


Employment and post-secondary educational activities for young adults with autism spectrum disorders during the transition to adulthood.

Taylor JL, Seltzer MM.

J Autism Dev Disord. 2011 May;41(5):566-74. doi: 10.1007/s10803-010-1070-3.


Changes in the autism behavioral phenotype during the transition to adulthood.

Taylor JL, Seltzer MM.

J Autism Dev Disord. 2010 Dec;40(12):1431-46. doi: 10.1007/s10803-010-1005-z.


Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice.

Frye CA, Llaneza DC.

Physiol Behav. 2010 Jun 1;100(3):264-7. doi: 10.1016/j.physbeh.2010.03.005. Epub 2010 Mar 16.


A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders.

Esbensen AJ, Greenberg JS, Seltzer MM, Aman MG.

J Autism Dev Disord. 2009 Sep;39(9):1339-49. doi: 10.1007/s10803-009-0750-3. Epub 2009 May 12.


Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.

Mandell DS, Morales KH, Marcus SC, Stahmer AC, Doshi J, Polsky DE.

Pediatrics. 2008 Mar;121(3):e441-8. doi: 10.1542/peds.2007-0984.


Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.

Aman MG, Vinks AA, Remmerie B, Mannaert E, Ramadan Y, Masty J, Lindsay RL, Malone K.

Clin Ther. 2007 Jul;29(7):1476-86.


Change in autism symptoms and maladaptive behaviors in adolescents and adults with an autism spectrum disorder.

Shattuck PT, Seltzer MM, Greenberg JS, Orsmond GI, Bolt D, Kring S, Lounds J, Lord C.

J Autism Dev Disord. 2007 Oct;37(9):1735-47. Epub 2006 Dec 5.

Supplemental Content

Support Center